Health Canada has finalized the second phase of amendments to modernize medical device establishment licensing in Canada. The amended Medical Devices Regulations were published in the Canada Gazette, Part II on June 17, 2026, and will come into force on December 14, 2026, 180 days after publication.
Unlike many regulatory changes that add new obligations, the Phase 2 amendments are designed to reduce burden on industry. Health Canada developed this phase with three stated goals: reducing regulatory burden, promoting innovation, and enhancing competitiveness. The changes affect companies that hold or plan to apply for a Medical Device Establishment Licence (MDEL), including manufacturers, importers, and distributors operating in the Canadian market.
Background on the MDEL Modernization Initiative
Health Canada committed to modernizing the MDEL framework in 2018-19, but the COVID-19 pandemic delayed the work. The first phase of amendments, which focused on modernizing compliance and enforcement oversight, was published in the Canada Gazette, Part II on June 17, 2024, and came into force on December 14, 2024.
For Phase 2, Health Canada pre-published the proposed amendments in the Canada Gazette, Part I on November 8, 2025, followed by a 75-day comment period. The department considered stakeholder feedback before finalizing the amendments published in June 2026. The details are outlined in Health Canada’s Phase 2 compliance bulletin, released June 17, 2026.
What the Phase 2 Amendments Change
The amended regulations introduce three key changes for MDEL applicants and holders.
1. Foreign Distributors No Longer Need Their Own MDEL in Certain Cases
The most significant change removes the requirement for foreign distributors to hold an MDEL when they sell their medical devices through Canadian importers that already hold one. For international companies distributing into Canada through licensed Canadian importers, this eliminates a layer of licensing that previously duplicated oversight already applied at the import stage.
Effective December 14, 2026, foreign distributors that sell medical devices exclusively through Canadian Importers holding a valid MDEL will generally no longer be required to obtain their own MDEL. However, foreign distributors supplying Canadian retailers, healthcare facilities, or other importers that do not hold an MDEL may still be required to maintain an MDEL, depending on their distribution arrangements.
2. Documented Procedures Requirements Are Clarified
The amendments clarify the existing requirement that MDEL holders must establish, implement, and maintain documented procedures. This does not create a new obligation, but it makes the expectation explicit in the regulations rather than leaving room for interpretation. Companies should still review their current procedures to confirm they are documented, implemented, and maintained as required.
The amendments explicitly reinforce the requirement for MDEL holders to establish, implement, and maintain documented procedures applicable to their licensed activities. These may include complaint handling, recalls, distribution records, incident reporting, serious-risk notifications, and appropriate handling, storage delivery, installation, corrective action, and servicing procedures. These applicable requirements depend on the establishment’s activities and the classes of medical devices handled.
3. Supplier Lists Become Part of the Application
MDEL applicants and holders will now be required to provide a list of suppliers for the medical devices they import or distribute in Canada. This change improves transparency around devices entering the Canadian market and supports Health Canada’s ability to trace products when safety concerns arise. Importers and distributors should begin compiling accurate supplier information now so it is ready when the requirement takes effect.
Under the amended regulations, MDEL applicants must provide supplier information, including each supplier’s name, address, and the risk classification (Class I, II, III or IV) of the medical devices supplied. Existing MDEL holders must maintain this information and provide updated supplier details as part of their annual licence review. The amendments do not introduce a general requirement to submit copies of documented procedures with MDEL application. However, these procedures must be available for Health Canada’s review or inspection when requested.
Updated Guidance Documents
Health Canada has updated four guidance documents to reflect the amendments:
- Guidance on medical device establishment licensing (GUI-0016)
- Medical device establishment licence application instructions (FRM-0292)
- How Health Canada inspects medical device establishments (GUI-0064)
- Risk classification guide for medical device establishment inspections (GUI-0079)
An important detail for licence holders: the updated versions will not replace existing guidance until the amendments come into force in December 2026. Until then, the current versions of these documents continue to apply. The amendments also streamline administrative requirements by removing certain procedural attestations and eliminating the requirement to report medical specialty information for each manufacturer.
What This Means for MDEL Holders
According to Health Canada, the amended regulations reduce burden for industry and clarify regulatory requirements without compromising health and safety. They also align Canadian requirements with international regulations and improve transparency around medical devices imported into Canada.
Over the six months leading up to the coming-into-force date, Health Canada will work with regulated parties to raise awareness and promote compliance. The department plans to send bulletins on compliance promotion activities and updates on guidance documents during this period.
Existing MDEL Holders should prepare their supplier information for submission through the Annual Licence Review (ALR) process and follow any additional instructions issued by Health Canada during implementation.
For most MDEL holders, the practical preparation is straightforward. Foreign distributors selling through licensed Canadian importers should confirm whether the exemption applies to their situation. All licence holders should verify that their documented procedures meet the clarified requirements and prepare their supplier lists ahead of their next application or renewal.
Frequently Asked Questions
Does the foreign distributor exemption apply automatically?
The exemption applies to foreign distributors selling their medical devices through Canadian importers that hold an MDEL. Foreign distributors should confirm that their Canadian import partners hold a valid licence and that their distribution arrangement fits the conditions described in the amended regulations. Companies with mixed distribution models, where some devices flow through licensed importers and others do not, should review each channel separately.
Do the Phase 2 amendments apply to all classes of medical devices?
The MDEL framework applies at the establishment level rather than the device class level. Any company holding or applying for an MDEL is subject to the amended requirements regardless of whether they handle Class I, II, III, or IV devices.
When do the updated guidance documents take effect?
Health Canada has published updated versions of GUI-0016, FRM-0292, GUI-0064, and GUI-0079, but these will only replace the existing guidance when the amendments come into force on December 14, 2026. Companies should continue following current guidance until then while familiarizing themselves with the updated versions.
Key Takeaways
- The Phase 2 amendments to the Medical Devices Regulations were published June 17, 2026, and come into force December 14, 2026.
- Foreign distributors will no longer need their own MDEL when selling through Canadian importers that hold one.
- The requirement for MDEL holders to establish, implement, and maintain documented procedures has been clarified.
- MDEL applicants and holders must provide a list of suppliers for the devices they import or distribute in Canada.
- Updated guidance documents (GUI-0016, FRM-0292, GUI-0064, GUI-0079) replace existing versions only when the amendments come into force in December 2026.
Preparing for December 2026
The Phase 2 amendments simplify parts of the MDEL framework, but companies still need to understand how the changes apply to their specific operations. Foreign distributors evaluating the exemption, importers preparing supplier lists, and licence holders reviewing their documented procedures all benefit from confirming their position before the December 14, 2026 coming-into-force date.
If you have questions about how the Phase 2 amendments affect your MDEL obligations, reach out to our team. Our regulatory specialists support medical device companies through MDEL registration and compliance at every stage of the licensing process.
